Trial Profile
Phase I Trial of Image Guided Focally Dose Escalated Prostate SBRT for Locally Recurrent Prostate Cancer After Prior Radiotherapy
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 20 Nov 2023
Price :
$35
*
At a glance
- Drugs Piflufolastat F18 (Primary)
- Indications Adenocarcinoma; Prostate cancer
- Focus Adverse reactions
- 10 Aug 2023 Planned End Date changed from 20 Dec 2028 to 16 Feb 2025.
- 10 Aug 2023 Status changed from recruiting to active, no longer recruiting.
- 19 Nov 2021 Planned number of patients changed from 52 to 46.